SlideServe
Menu
Préférences
© SlideServe · v2026

TOPIC: NEWER TREATMENT IN BREAST CANCER

naeva avatar
24 diapositives · 421 Views · Feb 20, 2014

Breast cancer remains a significant health challenge, affecting 1 in 8 women and being the second leading cause of cancer-related deaths. This presentation by Chaitra T.M., a 9th term student at Bangalore Medical College, explores the latest advancements in breast cancer treatment. Covering clinical staging, diagnostic innovations, and surgical techniques, the talk emphasizes patient involvement in education and the importance of early detection through self-examinations. The role of modern therapies, including immunotherapy and personalized medicine, is also discussed, highlighting the evolution of treatment options to improve outcomes and quality of life.

TOPIC: NEWER TREATMENT IN BREAST CANCER - slide 1
01 / 24TOPIC: NEWER TREATMENT IN BREAST CANCER
1 / 17

Télécharger la présentation

TOPIC: NEWER TREATMENT IN BREAST CANCER
Une image / un lien ci-dessous est fourni (tel quel) pour télécharger la présentation

Politique de téléchargement : le contenu du site vous est fourni TEL QUEL pour votre information et votre usage personnel ; il ne peut être vendu, concédé sous licence ni partagé sur d’autres sites sans l’accord de son auteur.Le contenu vous est fourni TEL QUEL, pour votre information et votre usage personnel uniquement. Téléchargez la présentation en cliquant sur ce lien. Lors du téléchargement, si vous ne parvenez pas à télécharger une présentation, l’éditeur a peut-être supprimé le fichier de son serveur.Pendant le téléchargement, si vous ne parvenez pas à obtenir une présentation, le fichier a peut-être été supprimé par l’éditeur.

F I N

Plus de contenu associé

Transcription de la présentation
  1. TOPIC: NEWER TREATMENT IN BREAST CANCER BY Chaitra.t.m 9th term Bangalore medical college

  2. TOPIC: NEWER TREATMENT IN BREAST CANCER BY Chaitra.t.m 9th term Bangalore medical college

  3. Chance of developing This at some Point of womens Life is 13% whereas in man is <2%. 2nd leading cause of death Breast cancer

  4. TYPES Lobular(15%) Ductular(85%)

  5. RISK FACTORS • AGE - MORE THAN 40yrs • GENDER- FEMALE • GEOGRAPHY- WESTERN COUNTRIES • ENDOCRINE- NULLIPAROUS • NO CHILD UPTO 30yrs • HARMONE REPLACEMENT THERAPY • NO BREAST FEEDING • HIGH FAT DIET • OCPs • OBESITY • GENETIC

  6. MYTHS ABOUT BREAST CANCER • Antiperspirents • Induced abortion • Breast implants • Environmental pollution • Night shift working Thought to be carcinogens

  7. CLINICAL STAGING TUMOUR SIZE Stage 0- DCIS Stage 1- tumour confined To breast & <2 cm Stage 2- 2-5cm , may involve Same side body lymph nodes Stage 3- >5cm, any lymph node No mets Stage 4- metastatic breast cancer NODES METASTASIS One more type of classification = manchesters

  8. PATIENT INVOLVEMENT • Health education Whats new in Breast cancer treatment • POST OP • Better arm function • Cosmesis • Quality of life • TECHNOLOGY • Diagnostic • Treatment

  9. SCREENING INVESTIGATIONS • Mammography – all patients with family history -Sensitive for even 2-3cm tumour

  10. 2. Clinical breast examination 3. Breast self examination

  11. DIAGNOSTIC INVESTIGATIONS • Diagnostic mammography • Ultrasonography • Biopsy - F N A C - core biopsy - surgical biopsy-lumpectomy/ stereotactic localisation (nonpalpable tumours) 4. Scintimammography (99mm Tc- Sestamibi) 5. MRI (localisation ) 6. CT 7. PET(mets work up & effective chemotherapy) METS WORK UP CXRLFTLIVER USG Isotope bone scan

  12. SURGERY Halsteds –radical mastectomy Patey’s –modified radical mastectomy BREAST CONSERVATIVE SURGERY= (wide local excision-margin +/-) /QUART {quadrantectomy+axillary dissection+ Radiotherapy} No lymphedema/no limb dysfunction new

  13. Breast reconstruction surgery After huge tumours resection • TRANS RECTUS ABDOMINUS flap • LATTISIMUS DORSI flap Breast prosthesis

  14. ADJUVANT THERAPY= (Chemotherapy/harmonotherapy/ radiotherapy/immunotherapy) .RADIOTHERAPY- 1. to tumour bed only 2.peroperative 3. palliative

  15. Chemotherapy- (given in 6 cycles at an interval of 28 days with heamatological monitoring) • conventional CMF regime • Newer less toxic drugs 1.anthracyclines-adriamycin/cyciophosphamide 2.taxanes-paclitaxel/docetaxel • Indications- • Lymph node positive tumour • Poor prognostic lymph node negative • As palliative therapy • As neoadjuvant therapy

  16. Hormonotherapy • Conventional oophorectomy • antioestrogens -SERMS-tamoxifen(gold standard) -aromatase inhibitor-anastrazole(postmenopausal women)ATAC trials show more beneficial in preventing reccurence • Estrogen receptor down regulator -fluvanstrant(once a month dose) ER ER

  17. HER2 receptor positive cancer (25%)do respond to herceptin (herceptin trial shows 50% relapse prevention) • FDA approved avastin is a trial drug which acts on VEGF preventing tumour progression

  18. Immunotherapy • Make tumour cells to be recognised as foreign • Boost up host immunity to destroy them

  19. In advanced breast carcinoma its less of surgery more of palliation therapy(hormonal/chemotherapy/radiotherapy)

  20. Australian couple who underwent fertility tretment following detection of massive cancer running in family.

  21. Complementary medicine • Meditation • Acupuncture • Nutrition • Vitamin tablets

  22. "The smaller the tumor, the greater your options. So if you feel something you're concerned about, you need to get in and get it taken care of . That's a key thing. Because a lot of people have this fear that they're going to lose their breast, and it's just not true anymore."

  23. Take home MESSAGE • Patient education regarding BSE (breast self examination) is the key point in our country. • With numerous options in treatment of carcinoma breast is now a realistic challenge to we doctors and we got to individualise the treatment

  24. THANK YOU